This presentation is about the validation of software. It focus on the validation of software used in pharmacy. It contains definition of validation, computer system and validation of computer system. It explains the models which are used for software validation and on example i.e. HPLC software validation.
In this slide contains Introduction, overview and details of FACTORY ACCEPTANCE TEST
Presented by: P.NARESH (Department of pharmaceutical analysis).RIPER, anantapur
This document discusses the validation of dry powder mixers, fluid bed dryers, and tray dryers used in pharmaceutical manufacturing. It describes the need for validation to ensure safety, reliability and consistent results. The validation process includes installation qualification to check equipment meets specifications, operational qualification to ensure proper functioning, and performance qualification to verify the equipment achieves expected results. Key parameters monitored include temperature, time, particle size and moisture content. The document provides details on qualification protocols and acceptance criteria to fully validate each piece of equipment.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
A system was built according to user requirements and design specifications. A validation plan was created to test the system through functional specifications, process qualification, operational qualification, and installation qualification to validate that the system meets requirements. A validation report was generated following the V-model concept of validation.
This document discusses the validation of a fluidized bed dryer. It begins with an introduction to fluidized bed drying and the construction and working of fluidized bed dryers. It then discusses the four stages of validation for equipment: design qualification, installation qualification, operational qualification, and performance qualification. For each stage, it provides details on the specific tests and documentation required for validating a fluidized bed dryer. It emphasizes establishing that the dryer will consistently and reliably perform its intended functions.
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
This presentation is about the validation of software. It focus on the validation of software used in pharmacy. It contains definition of validation, computer system and validation of computer system. It explains the models which are used for software validation and on example i.e. HPLC software validation.
In this slide contains Introduction, overview and details of FACTORY ACCEPTANCE TEST
Presented by: P.NARESH (Department of pharmaceutical analysis).RIPER, anantapur
This document discusses the validation of dry powder mixers, fluid bed dryers, and tray dryers used in pharmaceutical manufacturing. It describes the need for validation to ensure safety, reliability and consistent results. The validation process includes installation qualification to check equipment meets specifications, operational qualification to ensure proper functioning, and performance qualification to verify the equipment achieves expected results. Key parameters monitored include temperature, time, particle size and moisture content. The document provides details on qualification protocols and acceptance criteria to fully validate each piece of equipment.
It is process of “Establishing documentary evidence that provide a high degree of assurance that a specific process will consistently produce a product meeting its predetermined specifications and quality attributes”.
In the pharmaceutical industry, it is very important that in addition to final testing and compliance of products, it is also assured that the process will consistently produce the expected results.
Validation is action of proving in accordance with the principles of good manufacturing practices, that any procedure, process, equipment, material, activity or system actually leads to expected results.
Cleaning validation is documented evidence with a high degree assurance that one can consistently clean a system or a piece of equipment to predetermined and acceptable limits.
The primary regulatory concern driving the need for cleaning validation is cross contamination of the desired drug substance either by other API from previous batch runs or by residues from the cleaning agents used.
The prime purpose of validating a cleaning process is to ensure compliance with federal and other standard regulations
1. Cross contamination with active ingredients
Contamination of one batch of product with significant levels of residual active ingredients from previous batch cannot be tolerated.
In addition to the obvious problems posed by subjecting consumers or patients to unintended contaminants, potential clinically significant synergistic interactions between pharmacologically active chemicals are a real concern.
2. Contamination with unintended materials or compounds
While inert ingredients used in drug products are generally recognized as safe for human consumption, the routine use, maintenance and cleaning of equipment's provide the potential contamination with such items as equipment parts, lubricants and chemical cleaning agents3. Microbiological contamination
Maintenance , cleaning and storage conditions may provide adventitious microorganisms with the opportunity to proliferate within the processing equipment.
A system was built according to user requirements and design specifications. A validation plan was created to test the system through functional specifications, process qualification, operational qualification, and installation qualification to validate that the system meets requirements. A validation report was generated following the V-model concept of validation.
This document discusses the validation of a fluidized bed dryer. It begins with an introduction to fluidized bed drying and the construction and working of fluidized bed dryers. It then discusses the four stages of validation for equipment: design qualification, installation qualification, operational qualification, and performance qualification. For each stage, it provides details on the specific tests and documentation required for validating a fluidized bed dryer. It emphasizes establishing that the dryer will consistently and reliably perform its intended functions.
Aseptic / sterile- “ A state of control attained by using an aseptic work area and performing activities in a manner that precludes microbiological contamination of the exposed sterile product”
This document discusses pharmaceutical validation and process validation. It begins with an introduction to process validation, describing it as the analysis of data gathered throughout product design and manufacturing to confirm a process can reliably output products to a determined standard. It then covers the documentation of process validation, including validation master plans, protocols, and reports. The rest of the document discusses specific types of process validation and provides examples of validating different pharmaceutical dosage forms and processes.
Annual product reviews are conducted annually to assess the quality of drug products and determine if any changes need to be made to product specifications, manufacturing processes, or quality control procedures. The review evaluates analytical data, inspection results, batch failures, complaints, recalls, deviations, stability monitoring results, and corrective actions to verify process consistency and identify quality trends over time. The goal is to continually improve product quality and manufacturing processes.
Supplement 6- Annex9- WHO guideline: Temperature and humidity monitoring systems
Technical supplement to WHO Technical Report Series, No. 961, 2011 Annex 9: Model guidance for the storage and transport of time and temperature–sensitive pharmaceutical products
This document provides an overview of process validation according to FDA guidance. It defines process validation as collecting data from process design through commercial production to establish that a process is capable of consistently delivering quality products. The guidance outlines a lifecycle approach with three stages: process design, process qualification, and continued process verification. Process design defines the commercial process based on development knowledge. Process qualification evaluates the design and determines if the process is reproducible. Continued process verification ensures the process remains controlled during routine production. Critical quality attributes and critical process parameters are identified, and control strategies are established.
This presentation summarizes recommendations from an ISPE working group for assessing blend and content uniformity. The group proposed modifications to address issues with the withdrawn 2002 FDA guidance. Key recommendations include a two-stage blend testing approach using statistical analysis and flexibility in selecting sampling plans, acceptance criteria, and confidence/coverage levels using a risk-based approach.
This document discusses quality control tests for suppositories. It describes the different types of suppositories and various tests conducted during quality control, including visual examination, uniformity of weight and texture, melting point determination, breaking strength, dissolution testing, content uniformity, and disintegration testing. The goals of these tests are to ensure suppositories meet specifications for attributes like appearance, consistency, and ability to dissolve or disintegrate properly when administered.
The document discusses the construction, working, validation process, and qualification protocols for a fluidized bed dryer (FBD) used in pharmaceutical applications. It describes the key components of an FBD and the fluidization drying process. Validation of the FBD involves design, installation, operational, and performance qualifications to ensure proper functioning.
This document discusses process validation. It defines process validation as establishing documented evidence that a process will consistently produce a product meeting its predetermined specifications. The key aspects of process validation are to obtain consistent and reliable data, demonstrate that the process remains in control, and show the process works as intended. There are different types of process validation including prospective, retrospective, and concurrent validation. Process validation involves multiple phases from process design and qualification to process verification and monitoring. It is important for quality, safety, efficacy and compliance with global regulatory agencies.
This document discusses granulation processes and quality management in the pharmaceutical industry. It covers topics like cGMP, SUPAC guidelines for post-approval changes, validation of granulation equipment and processes, and questionnaires for auditing granulation. The key points are that granulation is a critical manufacturing step that must be validated; SUPAC provides guidance on composition, batch size, site and equipment changes; and validation involves qualifying equipment and demonstrating consistent product quality through processes.
The document discusses the validation of liquid oral dosage forms. It defines validation as providing a high degree of assurance that a specific manufacturing process will consistently produce a product meeting predetermined specifications. The validation of liquids includes qualifying equipment and facilities. Critical process parameters for manufacturing oral solutions, suspensions, and emulsions include mixing speed and time, homogenization speed and time, and filtration. Acceptance criteria include product clarity, viscosity, pH, assay, sedimentation volume, resuspension, and particle size. At least three successful validation batches are typically required to validate a new product or process.
The document discusses the validation of water supply systems for pharmaceutical use. It outlines the validation process, which includes design qualification to verify the system design, installation qualification to confirm proper installation, operation qualification to test system functionality under static conditions, and performance qualification to demonstrate consistent performance over time under normal operating conditions. Routine monitoring, maintenance, and change control procedures are also required to ensure continued system operation and water quality as specified.
Qualification of tablet compression machinePritam Kolge
The document discusses the qualification process for a tablet compression machine. It describes the steps of design qualification, installation qualification, operational qualification, and performance qualification. Design qualification establishes that the machine design meets requirements. Installation qualification verifies proper installation. Operational qualification tests machine functions and settings. Performance qualification evaluates the machine's process capability at different speeds. The results showed specifications were met at an optimum speed of 40 rpm.
The document provides an overview of the qualification process for high performance liquid chromatography (HPLC) equipment, including design qualification (DQ), installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). It describes the objectives and procedures for each qualification step. Key aspects covered include verifying design specifications, proper installation, operational requirements such as precision, accuracy and noise levels, and ongoing performance monitoring. The goal of qualification is to ensure analytical systems are suitable for their intended use and generate reliable results.
1) The document outlines the validation process for a tablet compression machine, including installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ).
2) The IQ establishes that the machine is installed correctly according to specifications. The OQ tests that the machine operates as intended at different speeds and settings.
3) The PQ evaluates the machine's compression capabilities by producing tablets and testing for characteristics like content uniformity, thickness, hardness, and friability. The validation protocol brings all stages together in a report.
The document discusses the validation of liquid oral dosage forms. It defines validation and its objectives, which include ensuring consistency and reproducibility of the manufacturing process. The key stages of validation are described - pre-validation qualification, process validation, and validation maintenance. For liquid orals, the validation would include equipment, raw materials, the manufacturing process, microbiological quality, product specifications, stability, and packaging. Critical process parameters are identified and acceptance criteria defined. The validation report and requirements for revalidation with changes are also summarized.
The document discusses various aspects of process validation for pharmaceutical products. It defines process validation as a documented program that provides a high degree of assurance a specific process will consistently produce a product meeting its predetermined specifications. It outlines the key stages of process validation including process design, process qualification, and continued process verification. The document also discusses validation of different dosage forms including solids, liquids, semisolids, and parenterals. It covers validation of various processes involved such as mixing, granulation, filling, and inspection. Validation of equipment and facilities is also summarized.
Qualification of Tablet Compression Machine.pptxDhruvi50
Tablet Compression Machine
Principle of Tablet Compression Machine
Construction of Tablet Compression Machine
Working of Tablet Compression Machine
Qualification of Tablet Compression Machine
Installation Qualification
Operational Qualification
Performance Qualification
References
This document provides an overview of air handling systems (AHUs) and HVAC qualification for pharmaceutical facilities. It contains sections on introduction, types of clean rooms, principles of clean rooms, HVAC components, regulatory requirements, contamination control, air flow patterns, and HVAC qualification steps including user requirement specification, design qualification, and installation qualification. The objective is to understand the need for pharmaceutical air handling systems and their technical and qualification requirements.
This document provides guidance on validation and qualification principles from the World Health Organization (WHO). It discusses the need for validation and qualification activities to ensure product quality, safety, and efficacy throughout the product lifecycle. Key aspects covered include definitions of validation terms, approaches to validation planning, and documentation requirements such as a validation master plan and protocols.
GAMP 5 provides guidance for computerized systems validation. It focuses on risk-based approaches and scalability of efforts based on a system's risk, complexity, and novelty. GAMP 5 also emphasizes leveraging supplier activities and avoiding duplication of efforts. The document provides a framework for life cycle activities from concept to retirement, including planning, specification, development, operation, and retirement of computerized systems.
This document discusses pharmaceutical validation and process validation. It begins with an introduction to process validation, describing it as the analysis of data gathered throughout product design and manufacturing to confirm a process can reliably output products to a determined standard. It then covers the documentation of process validation, including validation master plans, protocols, and reports. The rest of the document discusses specific types of process validation and provides examples of validating different pharmaceutical dosage forms and processes.
Annual product reviews are conducted annually to assess the quality of drug products and determine if any changes need to be made to product specifications, manufacturing processes, or quality control procedures. The review evaluates analytical data, inspection results, batch failures, complaints, recalls, deviations, stability monitoring results, and corrective actions to verify process consistency and identify quality trends over time. The goal is to continually improve product quality and manufacturing processes.
Supplement 6- Annex9- WHO guideline: Temperature and humidity monitoring systems
Technical supplement to WHO Technical Report Series, No. 961, 2011 Annex 9: Model guidance for the storage and transport of time and temperature–sensitive pharmaceutical products
This document provides an overview of process validation according to FDA guidance. It defines process validation as collecting data from process design through commercial production to establish that a process is capable of consistently delivering quality products. The guidance outlines a lifecycle approach with three stages: process design, process qualification, and continued process verification. Process design defines the commercial process based on development knowledge. Process qualification evaluates the design and determines if the process is reproducible. Continued process verification ensures the process remains controlled during routine production. Critical quality attributes and critical process parameters are identified, and control strategies are established.
This presentation summarizes recommendations from an ISPE working group for assessing blend and content uniformity. The group proposed modifications to address issues with the withdrawn 2002 FDA guidance. Key recommendations include a two-stage blend testing approach using statistical analysis and flexibility in selecting sampling plans, acceptance criteria, and confidence/coverage levels using a risk-based approach.
This document discusses quality control tests for suppositories. It describes the different types of suppositories and various tests conducted during quality control, including visual examination, uniformity of weight and texture, melting point determination, breaking strength, dissolution testing, content uniformity, and disintegration testing. The goals of these tests are to ensure suppositories meet specifications for attributes like appearance, consistency, and ability to dissolve or disintegrate properly when administered.
The document discusses the construction, working, validation process, and qualification protocols for a fluidized bed dryer (FBD) used in pharmaceutical applications. It describes the key components of an FBD and the fluidization drying process. Validation of the FBD involves design, installation, operational, and performance qualifications to ensure proper functioning.
This document discusses process validation. It defines process validation as establishing documented evidence that a process will consistently produce a product meeting its predetermined specifications. The key aspects of process validation are to obtain consistent and reliable data, demonstrate that the process remains in control, and show the process works as intended. There are different types of process validation including prospective, retrospective, and concurrent validation. Process validation involves multiple phases from process design and qualification to process verification and monitoring. It is important for quality, safety, efficacy and compliance with global regulatory agencies.
This document discusses granulation processes and quality management in the pharmaceutical industry. It covers topics like cGMP, SUPAC guidelines for post-approval changes, validation of granulation equipment and processes, and questionnaires for auditing granulation. The key points are that granulation is a critical manufacturing step that must be validated; SUPAC provides guidance on composition, batch size, site and equipment changes; and validation involves qualifying equipment and demonstrating consistent product quality through processes.
The document discusses the validation of liquid oral dosage forms. It defines validation as providing a high degree of assurance that a specific manufacturing process will consistently produce a product meeting predetermined specifications. The validation of liquids includes qualifying equipment and facilities. Critical process parameters for manufacturing oral solutions, suspensions, and emulsions include mixing speed and time, homogenization speed and time, and filtration. Acceptance criteria include product clarity, viscosity, pH, assay, sedimentation volume, resuspension, and particle size. At least three successful validation batches are typically required to validate a new product or process.
The document discusses the validation of water supply systems for pharmaceutical use. It outlines the validation process, which includes design qualification to verify the system design, installation qualification to confirm proper installation, operation qualification to test system functionality under static conditions, and performance qualification to demonstrate consistent performance over time under normal operating conditions. Routine monitoring, maintenance, and change control procedures are also required to ensure continued system operation and water quality as specified.
Qualification of tablet compression machinePritam Kolge
The document discusses the qualification process for a tablet compression machine. It describes the steps of design qualification, installation qualification, operational qualification, and performance qualification. Design qualification establishes that the machine design meets requirements. Installation qualification verifies proper installation. Operational qualification tests machine functions and settings. Performance qualification evaluates the machine's process capability at different speeds. The results showed specifications were met at an optimum speed of 40 rpm.
The document provides an overview of the qualification process for high performance liquid chromatography (HPLC) equipment, including design qualification (DQ), installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ). It describes the objectives and procedures for each qualification step. Key aspects covered include verifying design specifications, proper installation, operational requirements such as precision, accuracy and noise levels, and ongoing performance monitoring. The goal of qualification is to ensure analytical systems are suitable for their intended use and generate reliable results.
1) The document outlines the validation process for a tablet compression machine, including installation qualification (IQ), operational qualification (OQ), and performance qualification (PQ).
2) The IQ establishes that the machine is installed correctly according to specifications. The OQ tests that the machine operates as intended at different speeds and settings.
3) The PQ evaluates the machine's compression capabilities by producing tablets and testing for characteristics like content uniformity, thickness, hardness, and friability. The validation protocol brings all stages together in a report.
The document discusses the validation of liquid oral dosage forms. It defines validation and its objectives, which include ensuring consistency and reproducibility of the manufacturing process. The key stages of validation are described - pre-validation qualification, process validation, and validation maintenance. For liquid orals, the validation would include equipment, raw materials, the manufacturing process, microbiological quality, product specifications, stability, and packaging. Critical process parameters are identified and acceptance criteria defined. The validation report and requirements for revalidation with changes are also summarized.
The document discusses various aspects of process validation for pharmaceutical products. It defines process validation as a documented program that provides a high degree of assurance a specific process will consistently produce a product meeting its predetermined specifications. It outlines the key stages of process validation including process design, process qualification, and continued process verification. The document also discusses validation of different dosage forms including solids, liquids, semisolids, and parenterals. It covers validation of various processes involved such as mixing, granulation, filling, and inspection. Validation of equipment and facilities is also summarized.
Qualification of Tablet Compression Machine.pptxDhruvi50
Tablet Compression Machine
Principle of Tablet Compression Machine
Construction of Tablet Compression Machine
Working of Tablet Compression Machine
Qualification of Tablet Compression Machine
Installation Qualification
Operational Qualification
Performance Qualification
References
This document provides an overview of air handling systems (AHUs) and HVAC qualification for pharmaceutical facilities. It contains sections on introduction, types of clean rooms, principles of clean rooms, HVAC components, regulatory requirements, contamination control, air flow patterns, and HVAC qualification steps including user requirement specification, design qualification, and installation qualification. The objective is to understand the need for pharmaceutical air handling systems and their technical and qualification requirements.
This document provides guidance on validation and qualification principles from the World Health Organization (WHO). It discusses the need for validation and qualification activities to ensure product quality, safety, and efficacy throughout the product lifecycle. Key aspects covered include definitions of validation terms, approaches to validation planning, and documentation requirements such as a validation master plan and protocols.
GAMP 5 provides guidance for computerized systems validation. It focuses on risk-based approaches and scalability of efforts based on a system's risk, complexity, and novelty. GAMP 5 also emphasizes leveraging supplier activities and avoiding duplication of efforts. The document provides a framework for life cycle activities from concept to retirement, including planning, specification, development, operation, and retirement of computerized systems.
Dr. Mustafa DEĞERLİ - 2017 - Etkili bir kalite güvence sürecinin parçası olar...Dr. Mustafa Değerli
Değerli, M., Özbudak, E. K., Aytaç, A. A. ve Demirel, Ö. E. (2017). Etkili bir kalite güvence sürecinin parçası olarak proje seviyesindeki denetimler: Uygulanan pratikler ve öğrenilen dersler. On Birinci Ulusal Yazılım Mühendisliği Sempozyumu (UYMS 2017). Bildiri Kitabı, 1980, 391-402. ISSN: 1613-0073
Etkili Bir Kalite Güvence Sürecinin Parçası Olarak Proje Seviyesindeki Deneti...Dr. Mustafa Değerli
Değerli, M. (2017). Etkili Bir Kalite Güvence Sürecinin Parçası Olarak Proje Seviyesindeki Denetimler: Uygulanan Pratikler ve Öğrenilen Dersler, 1980, 391-402. ISSN: 1613-0073- http://ceur-ws.org/Vol-1980
Yönetim Sistemleri Belgelendirmesi ( ISO 9001, ISO 14001, ISO 27001, ISO 22000, ISO 45001, FSSC 22000, ISO 10002, ISO 50001, ISO 31000, ISO 22301, ISO 20000, BS 10012, ISO 27031, ISO 55001, ISO 18295)
Artan rekabet koşulları içerisinde organizasyonlar hedeflerine ulaşmak hizmet/ürün verimliliğini arttırmak, var olan süreçlerini daha etkin ve optimal biçimde kullanmak için değişik sistemler arayışı içerisindedir. Günümüzde var olan sistemlerden Kurumsal Süreç Yönetim(BPM) sistemi organizasyonların hedeflerine ulaşmadaki en etkili sistem olarak öne çıkmaktadır. Organizasyonlar bu sistemi bünyelerine uygularken var olan süreçleri gözden geçirerek hatalı, performansız veya eksik süreçlerde iyileştirmeler yaparak istenen hedeflere ulaşmada , ölçülebilir performans ve maliyet düşüşlerine ulaşabilir Böylece daha yönetilebilir ve rekabetçi
2. Neden Önemli?
Verimlilikte artış
Hizmet maliyetlerinde azalma
Yeni dozaj formlarının tasarımında daha hızlı ve
güvenilir şekilde ilerleme
AR-GE alanında ölçek büyütmede kolaylık
Ekipman bakımında kolaylık
Yüksek otomasyon
2
3. İş potansiyeli hakkında çalışan bilincinde artış
Otorite gereksinimlerinin karşılanması
İşlem ve bitmiş ürün testlerinde azalma
İşlem değerlendirmelerinde daha güvenilir, doğru ve
hızlı sonuç eldesi
İşlem ile ilgili başarısızlıklarda azalma
3
4. Genel Tanım
İmalat prosesinde istenen özellikte ilaç üretimini
sağlayarak, istenmeyen özellikte ürün üretiminin
engellenmesi için uyulması gereken kuralların ve
limitlerin belirlenmesi, bu şekilde üretimin
yapılabilirliğinin ve tekrarlanabilirliğin kanıtlanmasıdır.
Proses validasyon kalite sisteminin bir parçasıdır.
4
5. FDA’e Göre Proses Validasyon Nedir?
Proses validasyonu, prosesin tasarım adımından
başlayıp ticari boyut seri imalat aşamasına kadar,
bir prosesin devamlı olarak kaliteli bir ürünü
oluşturma kapasitesinin bilimsel kanıtını sunan
verilerin toplanması ve değerlendirilmesidir.
5
6. Avrupa İlaç Ajansı (European Medicines Agency,
EMA)’ya Göre Proses Validasyon?
Belirlenmiş parametreler dahilinde işleyen bir yöntemin,
önceden belirlenen spesifikasyonları ve kalite
özelliklerini karşılayan tıbbi bir ürüne dönüşebilmesi
amacıyla etkin ve tekrarlanabilir olarak
uygulanabilirliğinin dökümante edilerek sunulan
kanıtıdır.
6
8. Proses Analitik Teknolojisi
Nihai ürünün istenilen özellikte olması için kullanılacak her
maddenin, ürünün ve işlemlerin zamanında
değerlendirilmesidir.
Kalite sağlanamadığında anında müdahale edilmesini temin
etmektedir.
Ruhsat dosyalarına uyum nedeniyle innovasyonun
sağlanamadığı durumları engellemektedir.
8
9. Ürün Yaşam Döngüsü (Drug Product Life Cycle)
Ürünün AR-GE laboratuvarında başlayan
geliştirme sürecinden itibaren pazara
sunulup ticarileştirilerek geniş kitlelerce
kullanılmasına kadar devam eden
süreçteki tüm fazlara denir.
FDA’ye göre validasyon gerçekte üretim
aşamasından çok AR-GE’nin bir parçasıdır.
İstenen ürün spesifikasyonları bu aşamada
belirlenmektedir. 9
10. Üretim prosesinin kontrol edilebilirliği ve tek düze
üretimin mümkün olması da AR-GE aşamasında
prosesin karmaşıklığının azaltılması ile sağlanabilir.
Kullanılan maddelerin stabil olduğu koşullar iyice
araştırılmalıdır.
AR-GE boyutunda ve gerçek üretim serilerinde elde
edilen verilerle geniş ve kapsamlı bir kalite sistemi
oluşturulmalıdır. 10
11. Validasyon Master Planı
1.Planın amaçları
2.Planın kapsamı
3.Validasyonun kapsamı
4. Sorumluluklar
5.Proses ve tesis tanımları
11
6.Valide edilecek sistemlerin belirlenmesi
7. Genel kabul kriterleri
8.Validasyon takvimi
9. Personel ve donanımları
10.Destekleyici programlar